Phase I clinical and magnetic resonance imaging study of the vascular agent NGR-hTNF in patients with advanced cancers (EORTC study 16041).

Van Laarhoven, H. W. M.; Fiedler, W.; Desar, I. M. E.; van Asten, J. J. A.; Marréaud, S.; Lacombe, D.; Govaerts, A. S.; Bogaerts, J.; Lasch, P.; Timmer Bonte, J. N. H.; Lambiase, A.; Bordignon, Claudio; Punt, C. J. A.; Heerschap, A.; C. M. L., van Herpen